Parallel Advisors, LLC Ideaya Biosciences, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,260 shares of IDYA stock, worth $92,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,260
Previous 1,891
72.4%
Holding current value
$92,518
Previous $32,000
112.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IDYA
# of Institutions
220Shares Held
83.4MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$193 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$186 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$176 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$143 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$140 Million0.0% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.36B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...